Jonathan Stocker, Ph.D. is listed as an executive officer on 2 SEC Form D filings by 1 issuer between Mar 2018 and Dec 2020: Tetherex Pharmaceuticals Corp (Oklahoma City, OK — biotechnology — 2018–2020; $43M reported sold to 240 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
The issuer belongs to the sponsor group Tetherex (2 issuers, $26K reported sold, 2015–2025).
What this means A sponsor group is one team that sets up a new company for each deal. Tetherex has 2 companies on file and $26K reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Jonathan Stocker, Ph.D. and found 2 differences: No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.